Adrastea Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADRASTEA PHARMA, and what generic and branded alternatives to ADRASTEA PHARMA drugs are available?
ADRASTEA PHARMA has five approved drugs.
Summary for Adrastea Pharma
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Adrastea Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adrastea Pharma | NYSTATIN | nystatin | POWDER;TOPICAL | 065175-001 | Dec 17, 2004 | AT | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Adrastea Pharma | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 065220-001 | Jul 28, 2006 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Adrastea Pharma | COLISTIMETHATE SODIUM | colistimethate sodium | INJECTABLE;INJECTION | 064216-001 | Feb 26, 1999 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Adrastea Pharma | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 063000-001 | Sep 30, 1994 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Adrastea Pharma | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | INJECTABLE;INJECTION | 203110-001 | Jun 29, 2015 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
